Adverse effects of amiodarone: even after the end of treatment.
(1) Amiodarone, an antiarrhythmic agent, carries a risk of potentially serious pulmonary, cardiac, hepatic, thyroid, ocular, peripheral neurological and cutaneous (photosensitivity) adverse effects. (2) The average plasma elimination half-life of amiodarone is about 50 days. (3) In practice, patients receiving amiodarone must be carefully monitored, both during treatment and for at least three months (up to one year) after treatment is withdrawn.
D000638:Amiodarone / Q000008:administration & dosage / Q000009:adverse effects* / Q000378:metabolism / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D006207:Half-Life; D006801:Humans
D000889:Anti-Arrhythmia Agents; D000638:Amiodarone